Advisory Board Member
Mr. Wallach is currently CEO and President of Evogen Inc., a commercial stage biothreat detection and diagnostics company. Mr. Wallach was formerly Chairman, CEO and a member of the founding management team of Molecular Detection Inc., a commercial stage molecular diagnostics company. Previously, Mr. Wallach was CFO and a member of the founding management team of Aton Pharma, Inc. (Acquired by Valeant Pharmaceuticals), a specialty pharmaceutical company. Prior to Aton Pharma, he was Vice President of Finance and Operations and a member of the founding management team of Acuity Pharmaceuticals (Now Opko, NASDAQ: OPK), a technology spin out from the University of Pennsylvania. He is serving in both diagnostic development and commercial advisory capacities.